Simultaneous deprehensio pro TB infectio et resistentia ad RIF & NIH

Tuberculosis (TB), fecit by Mycobacterium tuberculosis, manet a global salutem periculum. Et augendae resistentia ad key tb medicamina velut rifampicin (RIF) et isonias (inh) discrimine et ortu impedimentum global TB control. Celeri et accurate Molecular test de TB et resistentia ad RIF & Inh commendatur per qui ad identify inficiuntur aegris opportune et providere eos congrua in tempore curatio.

Challenges

An Aestimari 10.6 million populus ceciderunt ill cum TB in MMXXI cum augmentum 4.5% a 10.1 decies in MMXX, unde in aestimatur 1.3 million mortes, pares ad CXXXIII per 100,000.

Medicamento-repugnans TB, praecipue MDR-TB (resistens ad RIF & Inh), quod magis afficiens global TB curatio et praeventionis.

Celerium simultaneous TB et RIF / Inh resistentia diagnosis instanter requiritur ad mane et magis efficaciora curatio comparari moram medicamento susceptibilitatem temptationis eventus.

Solution

Marcus & Micro-test est III-in-I TB deprehensio pro TB contagione / RIF & Nih resistentia deprehensio KItEnables agentibus diagnosis de TB et RIF / inh in unum deprehensio.

Melting curva technology realizes simultaneous deprehendatur TB et MDR-TB.

III-in-I TB / MDR-TB deprehensio determinandum TB infectio et key primum-linea medicamento (RIF / inh) resistentia enables opportune et accurate TB curatio.

Mycobacterium nucleic acidum et rifampicin, isoniazid resistentia deprehensio ornamentum (liquefactio curva)

Vel successfully realizes triplici TB testing (TB infectio, RIF & NIH resistentia) in unum deprehendatur!

Celebrisres:Available in 1.5-2 hrs cum automatic praecessi interpretatione obscuratis technica disciplina operationem;

Test Sample:1-3 ml sputum;

High sensibility:Analytica sensitivity de L Bacteria / ML ad TB et 2x103Bacteria / ML pro RIF / Inh repugnans bacteria, cursus reliable deprehensio usque ad humilis bacterial onerat.

Plures targets: TB, is6110; RIF-resistentia -rpob (DVII ~ DIII);

Inh-resistance- adhes / ahpc / katg CCCXV;

Quality sanatio:Cell Control enim sample qualitas sanatio ad redigendum falsum negativis;

Lata compatibility: Compatibility cum maxime amet PCR systems ad wide Lab accessibility;

Qui guidelines obsequio: Adhing ad qui guidelines ad administratione de medicamento repugnans tuberculosis, cursus fideles et relevance in orci usu.

ADMODO

ADMODO

Post tempus: Feb-01-2024